The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection
Open Access
Abstract
Influenza virus infection is responsible for significant morbidity and mortality in the pediatric and pregnant women populations, with deaths frequently caused by severe influenza-associated lower respiratory tract infection and acute respiratory distress syndrome (ARDS). An appropriate immune response requires controlling the viral infection through activation of antiviral defenses, which involves cells of the lung and immune system. High levels of viral infection or high levels of inflammation in the lower airways can contribute to ARDS. Pregnant women and young children, especially those born prematurely, may develop serious complications if infected with influenza virus. Vaccination against influenza virus will lead to lower infection rates and fewer complications, even if the vaccine is poorly matched to circulating viral strains. Maternal vaccination offers infants protection via antibody transmission through the placenta and breast milk. Despite the health benefits of the influenza vaccine, vaccination rates around the world remain well below targets. Trust in the use of vaccines among the public must be restored in order to increase vaccination rates and decrease the public health burden of influenza.Keywords
This publication has 246 references indexed in Scilit:
- Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older PersonsThe Journal of Infectious Diseases, 2012
- From “one medicine” to “one health” and systemic approaches to health and well-beingPreventive Veterinary Medicine, 2011
- Immunogenicity of Trivalent Influenza Vaccine in Extremely Low-birth-weight, Premature Versus Term InfantsThe Pediatric Infectious Disease Journal, 2011
- Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescentsVaccine, 2011
- Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their InfantsClinical Infectious Diseases, 2010
- Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 monthsVaccine, 2010
- Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 YearsThe Pediatric Infectious Disease Journal, 2010
- Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 2010
- The Persistent Legacy of the 1918 Influenza VirusNew England Journal of Medicine, 2009
- Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10Nature Medicine, 2009